Menu
Treatment Comparison

Synvisc-One vs Monovisc

Compare Synvisc-One and Monovisc single-injection hyaluronic acid knee treatments. Understand differences in molecular weight, manufacturers, costs, and effectiveness.

Side-by-Side Comparison

Molecular Weight

Synvisc-One Very high (6 million Daltons)
Monovisc High (1-2.9 million Daltons)

Volume per Injection

Synvisc-One 6 mL
Monovisc 4 mL

Manufacturer

Synvisc-One Sanofi
Monovisc DePuy Synthes (J&J)

FDA Approval Year

Synvisc-One 2009
Monovisc 2012

Cross-Linked

Synvisc-One Yes (hylan polymer)
Monovisc Yes

Self-Pay Cost

Synvisc-One $800-$1,200
Monovisc $700-$1,100

Bird Allergy Safe

Synvisc-One No
Monovisc No

Medicare Coverage

Synvisc-One Yes
Monovisc Yes

It Depends on Your Situation

Both are effective single-injection avian-derived treatments. Synvisc-One has higher molecular weight and more clinical data, while Monovisc comes from J&J's orthopedic division and may have different insurance coverage.

Best for: Synvisc-One for proven track record; Monovisc if your insurance or provider prefers it.

Two Single-Injection Powerhouses

When choosing between single-injection HA treatments, Synvisc-One and Monovisc are both excellent avian-derived options. Both deliver the full treatment in one office visit—but they come from different pharmaceutical giants with different formulations.


Side-by-Side Comparison

FactorSynvisc-OneMonovisc
ManufacturerSanofiDePuy Synthes (J&J)
Injections needed11
Volume6 mL4 mL
Molecular weightVery high (6M Da)High (1-2.9M Da)
SourceAvianAvian
Cross-linkedYesYes
FDA approval20092012
Duration of reliefUp to 6 monthsUp to 6 months
Self-pay cost$800-$1,200$700-$1,100

Synvisc-One: The First Single-Shot

What It Is

Synvisc-One was the first single-injection HA product to reach the US market. Made by Sanofi (a global pharmaceutical leader), it contains hylan G-F 20—the same formula as the original three-injection Synvisc, but in one concentrated dose.

Key Advantages

Highest molecular weight - 6 million Daltons, potentially superior cushioning
Most clinical evidence - First to market, most studied
Proven track record - Since 2009, millions of injections given

Considerations

Larger volume - 6 mL may cause more initial swelling
Higher average cost - Typically $100-200 more than Monovisc

Monovisc: The J&J Contender

What It Is

Monovisc comes from DePuy Synthes, Johnson & Johnson’s orthopedic division—the same company that makes joint replacements. It’s essentially a single-injection version of their established Orthovisc product.

Key Advantages

Smaller volume - 4 mL may mean less post-injection discomfort
Often lower cost - Typically $100-200 less than Synvisc-One
J&J backing - Major orthopedic company with comprehensive joint expertise

Considerations

Less clinical history - Approved 3 years later than Synvisc-One
Lower molecular weight - Though still in the “high” category

The Molecular Weight Question

Does higher molecular weight mean better results? Here’s what we know:

TheoryEvidence
Higher MW = more cushioningLogical, but not proven in trials
Higher MW = longer durationNot consistently demonstrated
Both are “high” MWTrue—both exceed natural synovial fluid

Clinical reality: Head-to-head studies haven’t shown meaningful differences in patient outcomes between different molecular weight products. Both Synvisc-One and Monovisc provide effective relief.


Allergy Considerations

Both Require Allergy Screening

Neither Synvisc-One nor Monovisc is safe for patients with:

  • Egg allergies
  • Chicken allergies
  • Feather allergies
  • Any poultry sensitivity

If you have avian allergies, consider Durolane (single-injection, non-avian) or Euflexxa (three-injection, non-avian).


Cost and Insurance

FactorSynvisc-OneMonovisc
Self-pay$800-$1,200$700-$1,100
Medicare typical$100-$350$100-$300
Insurance preferenceVariesVaries

Pro tip: Some insurance plans have contracts that favor one product over the other. Ask your provider which is preferred by your specific plan to minimize out-of-pocket costs.


Making Your Decision

Lean toward Synvisc-One if:

  • You want the highest molecular weight available
  • You prefer the most established single-injection option
  • Your provider has extensive Synvisc experience
  • Your insurance covers it equally

Lean toward Monovisc if:

  • Cost is a significant factor
  • You prefer smaller injection volume
  • Your insurance prefers J&J products
  • You’ve used Orthovisc successfully before

Questions for Your Doctor

  1. Which product does my insurance prefer?
  2. What’s your experience with each product?
  3. Have you noticed any differences in patient outcomes?
  4. Which has better availability in your office?
  5. Given my specific situation, which would you recommend?

The Bottom Line

Both Are Solid Choices

Synvisc-One and Monovisc are both proven single-injection treatments from major pharmaceutical companies. The differences are subtle:

  • Synvisc-One: Higher molecular weight, more clinical data, slightly higher cost
  • Monovisc: Smaller volume, often lower cost, J&J orthopedic expertise

For most patients, either will work well. Let insurance coverage, provider preference, and cost guide your decision.

Find Single-Injection Providers

Connect with specialists experienced in both Synvisc-One and Monovisc.

Imaging-Guided Medicare Accepted

Used to find providers in your area

Required to submit this form

Your information is secure. See our Privacy Policy and Terms of Service.

Thank You!

We've received your request. A provider specialist will contact you within 1-2 business days to help you find the right care.

What happens next?

  • 1 We'll verify your insurance coverage
  • 2 Match you with quality providers in your area
  • 3 Contact you to discuss your options

Questions? Browse our guides:

How to Choose a Provider

Stay Informed on HA Options

Get the latest comparisons and guidance for knee osteoarthritis treatments.

You're in! Check your inbox.

Join 10,000+ readers. No spam.

Still Not Sure?

Take our quick assessment to find which treatment might be right for your specific situation.